U.S. market Open. Closes in 5 hours 41 minutes

HROWL | Harrow Health, Inc. 8.625% Senior Notes due 2026 Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Revenue130.19M88.59M72.48M48.87M51.16M41.37M
Cost of Revenue39.64M25.38M18.21M14.46M16.75M16.52M
Gross Profit90.55M63.21M54.26M34.41M34.42M24.85M
Operating Expenses89.97M61.29M52.40M33.66M35.18M30.07M
Selling, General & Admin83.09M58.24M41.31M31.25M33.10M29.24M
Research & Development6.88M3.05M11.08M2.41M2.08M825.00K
Other Operating Expenses-444.00K-15.93M-19.49M-3.80M630.00K103.00K
Operating Income580.00K-1.75M-284.00K-1.63M-503.00K-5.22M
Other Expenses / Income-24.52M-12.27M-17.59M-1.78M378.00K22.57M
Before Tax Income-23.94M-14.01M-17.87M-3.42M-125.00K14.62M
Income Tax Expenses470.00K75.00K133.00K4.00K2.47M-19.45M
Net Income-24.41M-14.09M-18.01M-3.42M-2.59M14.62M
Interest Expenses21.32M7.24M-5.44M-2.24M-2.50M-2.73M
Basic Shares Outstanding32.62M27.46M26.76M25.90M25.32M23.81M
Diluted Shares Outstanding32.62M27.46M26.76M25.90M26.47M23.81M
EBITDA12.92M1.92M2.11M1.11M2.16M-2.98M
EBITDA Margin9.92%2.17%2.91%2.27%4.22%-7.21%
EBIT-2.62M-6.77M-23.31M-5.65M-2.62M-7.55M
EBIT Margin-2.01%-7.64%-32.16%-11.56%-5.13%-18.25%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙